UUQ-61195-60874
2 vaccinations
4 coded responses
23 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 606 / IL
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to workAdult check-in
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-17
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-18
- 2021-01-19
-
2021-01-22
Health check-in — day 7, dose 1Feeling: Poor · Fever · Headache, Muscle or body aches, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-27
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-03
Health check-in — day 0, dose 2Feeling: Poor · Fever · Chills, Headache, Nausea, Abdominal painAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Diarrhea · Be unable to workAdult check-in
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Diarrhea · Be unable to workAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling, Itching · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache · Be unable to workAdult check-in
-
2021-02-10
Health check-in — day 7, dose 2Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Enlarged lymph node behind earMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-24
- 2021-03-04
- 2021-03-12
-
2021-03-17
Survey response — day 42, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: ASwollen lymph nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-04
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: PoorFree text: Have a coldMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-14 | priority 2/3 | |
| 2021-01-15 | priority 2/3 | |
| 2021-01-17 | priority 2/3 |
Free text
Release 4 — day 14, dose 2
Symptoms: Enlarged lymph node behind ear
Release 5 — day 42, dose 2
Symptoms: ASwollen lymph node
Release 8 — 3 months, dose 2
Symptoms: Pregnancy
Release 9 — 6 months, dose 2
Symptoms: Have a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release